12:00 AM
Jan 04, 2010
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 12/31 cls
BioMS Medical Corp. (TSX:MS) Hapoalim Raghuram Selvaraju Upgrade Hold (from sell) -4% C$0.33
Rodman Elemer Piros Upgrade Market perform (from underperform)
Selvaraju upgraded after BioMS announced that it terminated development of dirucotide and made a C$12M ($11.2M) equity investment in Spectral Diagnostics Inc....

Read the full 489 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >